BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25831745)

  • 1. [Microtubule depolymerization inhibitor].
    Kouno T
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():167-73. PubMed ID: 25831745
    [No Abstract]   [Full Text] [Related]  

  • 2. Microtubule-targeting drugs and personalization of cancer treatment.
    Rodríguez-Antona C; Gréen H
    Pharmacogenomics; 2011 Apr; 12(4):449-51. PubMed ID: 21521015
    [No Abstract]   [Full Text] [Related]  

  • 3. [Microtubule polymerization inhibitors].
    Takahata T; Sato A; Saito K; Yamagata K
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():162-6. PubMed ID: 25831744
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics, metabolites, and preclinical safety of vinflunine.
    Lobert S; Puozzo C
    Semin Oncol; 2008 Jun; 35(3 Suppl 3):S28-33. PubMed ID: 18538176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtubule active agents: beyond the taxane frontier.
    Morris PG; Fornier MN
    Clin Cancer Res; 2008 Nov; 14(22):7167-72. PubMed ID: 19010832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epothilones: a novel class of microtubule-stabilizing drugs for the treatment of cancer.
    Trivedi M; Budihardjo I; Loureiro K; Reid TR; Ma JD
    Future Oncol; 2008 Aug; 4(4):483-500. PubMed ID: 18684060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction. The novel microtubule inhibitor vinflunine.
    Horwitz SB
    Semin Oncol; 2008 Jun; 35(3 Suppl 3):S1-2. PubMed ID: 18538173
    [No Abstract]   [Full Text] [Related]  

  • 8. Microtubules: a dynamic target in cancer therapy.
    Pasquier E; Kavallaris M
    IUBMB Life; 2008 Mar; 60(3):165-70. PubMed ID: 18380008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into mechanisms of resistance to microtubule inhibitors.
    Ganguly A; Cabral F
    Biochim Biophys Acta; 2011 Dec; 1816(2):164-71. PubMed ID: 21741453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinflunine: a new microtubule inhibitor agent.
    Bennouna J; Delord JP; Campone M; Nguyen L
    Clin Cancer Res; 2008 Mar; 14(6):1625-32. PubMed ID: 18347163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential mechanisms of resistance to microtubule inhibitors.
    Kavallaris M; Annereau JP; Barret JM
    Semin Oncol; 2008 Jun; 35(3 Suppl 3):S22-7. PubMed ID: 18538175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubulin and microtubules as targets for anticancer drugs.
    Hadfield JA; Ducki S; Hirst N; McGown AT
    Prog Cell Cycle Res; 2003; 5():309-25. PubMed ID: 14593726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubule depolymerization and tau phosphorylation.
    Hernández F; García-García E; Avila J
    J Alzheimers Dis; 2013; 37(3):507-13. PubMed ID: 23948896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in the study of tubulin inhibitors].
    Shang H; Pan L; Yang S; Chen H; Cheng MS
    Yao Xue Xue Bao; 2010 Sep; 45(9):1078-88. PubMed ID: 21351562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ixabepilone: new drug. Similar to taxanes, but no better.
    Prescrire Int; 2009 Aug; 18(102):160. PubMed ID: 19743574
    [No Abstract]   [Full Text] [Related]  

  • 16. Miniaturization and validation of a sensitive multiparametric cell-based assay for the concomitant detection of microtubule-destabilizing and microtubule-stabilizing agents.
    Vassal E; Barette C; Fonrose X; Dupont R; Sans-Soleilhac E; Lafanechère L
    J Biomol Screen; 2006 Jun; 11(4):377-89. PubMed ID: 16751334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can mutations in gamma-actin modulate the toxicity of microtubule targeting agents?
    Fojo T
    J Natl Cancer Inst; 2006 Oct; 98(19):1345-7. PubMed ID: 17018774
    [No Abstract]   [Full Text] [Related]  

  • 18. Indibulin, a novel microtubule inhibitor, discriminates between mature neuronal and nonneuronal tubulin.
    Wienecke A; Bacher G
    Cancer Res; 2009 Jan; 69(1):171-7. PubMed ID: 19118000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the microtubules in breast cancer beyond taxanes: the epothilones.
    Cortes J; Baselga J
    Oncologist; 2007 Mar; 12(3):271-80. PubMed ID: 17405891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theaflavins depolymerize microtubule network through tubulin binding and cause apoptosis of cervical carcinoma HeLa cells.
    Chakrabarty S; Das A; Bhattacharya A; Chakrabarti G
    J Agric Food Chem; 2011 Mar; 59(5):2040-8. PubMed ID: 21323312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.